Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycin to Improve Latency in Exam Indicated Cerclage: a Randomized Control Trial

NCT05132829 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05132829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05132829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycin to Improve Latency in Exam Indicated Cerclage: a Randomized Control Trial
Lead sponsor
Thomas Jefferson University
Phase
Phase 4
Overall status
Unknown status
Start date
December 20, 2021
Completion date
June 30, 2025
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anti-bacterial agents, azithromycin, cefazolin, obstetric labor complications, obstetric labor, premature, physiological effects of drugs, pregnancy complications, preterm birth, uterine cervical incompetence